Login


TI Ref No : 521274969
Description : Ocrelizumab Inj 300mg Vial .#* Srphc064013-ocrelizumab Inj 300mg Vial Unit-vial. [quantity Tolerance (+/-): 5 %age , Item Category : Normal , Total Po Value Variation Permitted: Ma x 8 Lacs ] ]
Date : 2025-08-04
Deadline : 2025-12-31
Document Type : Contracts
View Details
Whats app